Compliance: Clear communication's critical [2]

British Journal of Ophthalmology

Volumn 89, Issue 10, 2005, Pages 1370-

  Buller, A J ^a   Connell, B ^a   Spencer, A F ^a  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; EYE DROPS; LATANOPROST; ANTIHYPERTENSIVE AGENT;

ADULT; CHRONIC DISEASE; CONJUNCTIVA; CONTROLLED STUDY; FEMALE; GENERAL PRACTITIONER; GLAUCOMA; HUMAN; INFORMATION PROCESSING; INTERPERSONAL COMMUNICATION; LETTER; MAJOR CLINICAL STUDY; MALE; NURSING; NURSING STAFF; PRIORITY JOURNAL; WARD; DOCTOR PATIENT RELATION; PATIENT COMPLIANCE;

ANTIHYPERTENSIVE AGENTS; COMMUNICATION; GLAUCOMA; HUMANS; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS;

EID: 27744503629     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2005.066175     Document Type: Letter

References (3)

1. Schwartz GF. Persistency and tolerability of ocular hypotensive agents: population-based evidence in the management of glaucoma. Am J Ophthalmol 2004;137(Suppl):S1-S2.
2. Reardon G, Schwartz GF, Mozarfari E. Patient persistency with topical ocular hypotensive therapy in a managed care population. Am J Ophthalmol 2004;137(Suppl):S3-S12.
3. MacKean JM, Elkington AR. Compliance with treatment of patients with chronic open-angle glaucoma. Br J Ophthalmol 1983;67:46-9.